Is prophylactic cranial irradiation a possible option for human epidermal growth factor receptor 2-positive breast cancer? [5]

Journal of Clinical Oncology

Volumn 25, Issue 10, 2007, Pages 1292-

  Buyukhatipoglu, Hakan ^a   Sevinc, Alper ^a   Pehlivan, Yavuz ^a   Camci, Celalettin ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

BRAIN METASTASIS; BREAST CANCER; CANCER PREVENTION; CANCER SURVIVAL; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; PROTEIN EXPRESSION; SKULL IRRADIATION; BRAIN TUMOR; BREAST TUMOR; CHEMISTRY; FEMALE; METASTASIS; NOTE; PATHOLOGY;

BRAIN NEOPLASMS; BREAST NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HUMANS; RECEPTOR, ERBB-2;

EID: 34247139276     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.10.1253     Document Type: Letter

References (5)

1. Gabos Z, Sinha R, Hanson J, et al: Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol 24:5658-5663, 2006
2. Tham YL, Sexton K, Kramer R, et al: Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 107:696-704, 2006
3. Lee JJ, Bekele BN, Zhou X: Decision analysis for prophylactic cranial irradiation for patients with small-cell lung cancer. J Clin Oncol 24:3597-3603, 2006
4. Belka C, Budach W, Kortmann RD, et al: Radiation induced CNS toxicity-molecular and cellular mechanisms. Br J Cancer 85:1233-1239, 2001
5. Smith TJ, Davidson NE, Schapira DV, et al: American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 17:1080-1082, 1999